Allergy Funding: How Much Did They Raise & Key Investors

How Much Did Allergy Raise?
Funding & Key Investors

Allergy, Asthma & Immunology of the Rockies, P.C. has successfully secured a significant capital injection, bringing its total funding to $150K. This latest financial milestone, characterized by a $150K major strategic investment, underscores the organization's robust position within the specialized healthcare sector. By leveraging this influx of resources, the clinic aims to fortify its operational infrastructure and expand its diagnostic capabilities across the Roaring Fork and Eagle Valley regions.

The infusion of capital serves as a testament to the clinic's long-standing commitment to providing comprehensive immunological care. As the healthcare landscape shifts toward more integrated, patient-centric models, this financing round positions the entity to scale its specialized services effectively, ensuring that both pediatric and adult populations receive high-quality, evidence-based treatments for complex allergic and respiratory conditions.

What is Allergy?

Allergy

Hospitals & Physicians Clinics

Physicians Clinics

Medical Practice Management

Operating as a premier full-service allergy clinic, Allergy, Asthma & Immunology of the Rockies, P.C. provides critical diagnostic and therapeutic interventions for a wide spectrum of conditions, including allergic rhinitis, asthma, and complex gastrointestinal disorders. Under the leadership of Dr. Robert McDermott, the practice has established itself as a cornerstone of medical excellence in its service areas since 2008. The clinic distinguishes itself through a rigorous, board-certified approach to internal medicine and immunology, offering advanced procedures such as rapid desensitization, pulmonary function testing, and comprehensive venom and food allergy diagnostics. By maintaining a focus on high-level patient satisfaction and clinical precision, the organization has cultivated a reputation for reliability in managing chronic nasal congestion, eczema, and severe anaphylactic reactions.

How much funding has Allergy raised?

Allergy has raised a total of $150K across 1 funding round:

2020

Debt

$150K

Debt (2020): $150K with participation from PPP

Key Investors in Allergy

PPP

Public-Private Partnership

What's next for Allergy?

With the recent strategic investment, the organization is poised to enter a new phase of growth, focusing on the optimization of its clinical workflows and the potential expansion of its testing facilities. The capital will likely be directed toward enhancing the technological stack used for environmental and drug allergy testing, thereby increasing throughput without compromising the quality of care. Furthermore, the clinic is expected to explore deeper integration of its immunotherapy programs, potentially broadening its reach to underserved patient demographics within the region. As the practice continues to navigate the complexities of modern healthcare, this financial backing provides the necessary runway to innovate in the delivery of specialized immunological services, ensuring long-term sustainability and continued excellence in patient outcomes.

See full Allergy company page

See More Financial Insights